{"id":"W2970304599","doi":"10.1200/jco.2013.31.15_suppl.9032","title":"Final efficacy results of NCIC CTG IND.202: A randomized phase II study of recombinant interleukin-21 (rIL21) in patients with recurrent or metastatic melanoma (MM).","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Jewish General Hospital; Queen Elizabeth II Health Sciences Centre; Baker Hughes (Canada); Ottawa Hospital; BC Cancer Agency; Queen's University; Hôpital Notre-Dame; Royal Victoria Hospital; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Dacarbazine; Internal medicine; Rash; Gastroenterology; Adverse effect; Phases of clinical research; Nausea; Population; Neutropenia; Melanoma; Hazard ratio; Surgery; Toxicity; Oncology; Chemotherapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002102565,0.001436905,0.001560781,0.0003620831,0.0003565504,0.0007177024,0.000692187,0.001500031,0.004615214],"category_scores_gemma":[0.001347788,0.0004343427,0.001076283,0.0002850487,0.0007284408,0.0005597906,0.0002920857,0.002063787,0.001031355],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008940272,"about_ca_system_score_gemma":0.00135367,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0009688367,"about_ca_topic_score_gemma":0.002873389,"domain_scores_codex":[0.9994191,0.0003628804,0.00002575953,0.00006705776,0.00004645598,0.0000788028],"domain_scores_gemma":[0.9991867,0.0001688054,0.0001384456,0.00004558661,0.00005433032,0.0004061343],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9230613,0.0159347,0.002487849,0.0005906303,0.0005896454,0.0001601208,0.00009220677,0.0009312417,0.01312112,0.0001618695,0.005339807,0.03752961],"study_design_scores_gemma":[0.8401696,0.1521748,0.003720079,0.00002821272,0.0003070463,0.00009928907,0.00001375141,0.0005353246,0.0009604233,0.00009307866,0.001879157,0.0000192701],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757316,0.00457835,0.0008680639,0.001531018,0.0003974139,0.007892078,0.003738235,0.0002308969,0.005032312],"genre_scores_gemma":[0.9745147,0.001766804,0.00197002,0.003127287,0.0004057121,0.0071389,0.006351964,0.00005144998,0.004673182],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004615214,"threshold_uncertainty_score":0.01543945,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1107869043427975,"score_gpt":0.4519686521981819,"score_spread":0.3411817478553844,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}